{
  "case_id": "case_0005",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 41.05,
    "sex": "Female",
    "genderIdentity": "Cisgender Male",
    "ancestry": "Sub-Saharan African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- left optic nerve and right cerebellum.",
      "structured_data": {
        "gt_lesions_english": [
          "right cerebellum",
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "optic nerve",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "cerebellar hemisphere",
            "side": "right",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)",
          "right cerebellum"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid, CNS Vasculitis and ADEM.\n\nOther possible differentials:\n- SLE and Neurosyphilis.\n- Also feasible but low probability: Lyme, Beh\u00e7et's, Lymphoma, Susac Syndrome and Sjogren's.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Paraneoplastic cerebellar degeneration with optic neuropathy (Technically feasible explanation for all signs, but proposes multiple separate pathologies; less parsimonious than a unifying diagnosis)\n- Vitamin B12 deficiency (subacute combined degeneration) (plausible for unilateral cerebellum, but atypical for unilateral optic nerve involvement)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Relapsing\u2013remitting multiple sclerosis",
          "Neuromyelitis optica spectrum disorder",
          "Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease",
          "Neurosarcoidosis",
          "Primary CNS vasculitis",
          "Paraneoplastic cerebellar degeneration with optic neuropathy",
          "Vitamin B12 deficiency (subacute combined degeneration)",
          "Infectious or post-infectious demyelinating encephalomyelitis"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "ADEM",
          "CNS_Vasculitis",
          "MOGAD",
          "AQP4_NMOSD",
          "MS",
          "Neurosarcoidosis"
        ],
        "missing_lesion_dx_keys": [
          "Infection_Lyme",
          "Behcet_Disease",
          "Autoimmune_Myelitis_SLE",
          "CNS_Lymphoma",
          "Susac_Syndrome",
          "Autoimmune_Myelitis_Sjogren",
          "Syphilis"
        ],
        "missing_common_names": [
          "SLE",
          "Neurosyphilis"
        ],
        "missing_low_prob_names": [
          "Lyme",
          "Beh\u00e7et's",
          "Lymphoma",
          "Susac Syndrome",
          "Sjogren's"
        ],
        "additional_diagnoses": [
          "Paraneoplastic cerebellar degeneration with optic neuropathy",
          "Vitamin B12 deficiency (subacute combined degeneration)"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 2,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 13,
        "lesion_ddx_matched_count": 6,
        "lesion_ddx_missed_common_count": 2,
        "lesion_ddx_missed_low_prob_count": 5,
        "lesion_ddx_coverage_percentage": 0.46153846153846156
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Orbits and Brain and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: ESR, ANA, ANCA, HIV, CRP, anti-MOG, syphilis, ACE, ENA, lyme, anti-AQP4.\n- Could also consider testing: fluorescein angiography, audiometry, anti-dsDNA, CSF (cytology and flow cytometry).",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of brain and orbits with gadolinium contrast",
          "MRI of cervical and thoracic spine with gadolinium contrast",
          "Lumbar puncture for CSF oligoclonal bands",
          "CSF cell count and differential",
          "CSF protein",
          "CSF glucose",
          "CSF bacterial culture",
          "CSF viral PCR panel",
          "Visual evoked potentials",
          "Optical coherence tomography of optic nerves and maculae",
          "Automated visual field testing",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Serum vitamin B12",
          "Serum folate",
          "Thyroid function tests",
          "Fasting blood glucose",
          "Serum calcium",
          "Serum angiotensin-converting enzyme level",
          "Antinuclear antibody",
          "Extractable nuclear antigen panel",
          "Antineutrophil cytoplasmic antibodies",
          "Serum aquaporin-4 IgG antibody",
          "Serum MOG IgG antibody",
          "Serum protein electrophoresis and immunoglobulins",
          "HIV serology",
          "Syphilis serology",
          "Lyme disease serology (depending on epidemiology)",
          "Chest X-ray",
          "CT of chest, abdomen and pelvis (if paraneoplastic syndrome suspected)"
        ],
        "all_identified_ft_keys": [
          "Bone_Profile",
          "ANA",
          "ANCA",
          "LFT",
          "Vitamin_B12",
          "MOG_Antibodies",
          "VEP",
          "FBC",
          "Serum_ACE",
          "CSF_General",
          "ENA_Panel",
          "Lyme_Serology",
          "Chest_XRay",
          "MRI_Cervical_Spine",
          "Serum_Protein_Electrophoresis",
          "U_and_E",
          "MRI_Brain",
          "Automated_Visual_Fields",
          "ESR",
          "TFT",
          "Serum_Immunoglobulins",
          "OCT",
          "CSF_Oligoclonal_Bands",
          "Folate",
          "HIV_Test",
          "Chest_CT",
          "CRP",
          "MRI_Thoracic_Spine",
          "Syphilis_Serology",
          "Blood_Cultures",
          "Glucose_HbA1c",
          "CSF_Viral_PCR",
          "AQP4_Antibodies",
          "MRI_Orbits"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [],
        "expected_inv_keys_ddx": [
          "Fluorescein_Angiography",
          "ESR",
          "ANA",
          "Audiometry",
          "ANCA",
          "HIV_Test",
          "CSF_Cytology",
          "CRP",
          "MOG_Antibodies",
          "Syphilis_Serology",
          "Serum_ACE",
          "ENA_Panel",
          "Lyme_Serology",
          "Anti_dsDNA",
          "AQP4_Antibodies",
          "CSF_Flow_Cytometry"
        ],
        "found_inv_keys_ddx": [
          "ESR",
          "ANA",
          "ANCA",
          "HIV_Test",
          "CRP",
          "MOG_Antibodies",
          "Syphilis_Serology",
          "Serum_ACE",
          "ENA_Panel",
          "Lyme_Serology",
          "AQP4_Antibodies"
        ],
        "missing_inv_keys_ddx": [
          "Fluorescein_Angiography",
          "Audiometry",
          "CSF_Cytology",
          "Anti_dsDNA",
          "CSF_Flow_Cytometry"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 3,
        "primary_tests_found_count": 3,
        "primary_tests_missed_count": 0,
        "primary_tests_coverage_percentage": 1.0,
        "ddx_tests_expected_count": 16,
        "ddx_tests_found_count": 11,
        "ddx_tests_coverage_percentage": 0.6875
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nCorrectly identified the following:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not specified, so no indication what the current issue is and whether neurological signs are new or old.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Inpatient admission under neurology",
            "timing": "Start Now",
            "reasons": [
              "Requires urgent MRI and lumbar puncture for diagnosis",
              "Needs supervised high-dose intravenous steroids and monitoring for adverse effects",
              "Gait ataxia increases falls risk requiring supervised mobility assessment"
            ]
          },
          {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute optic neuritis and cerebellar relapse causing functional impairment",
              "High-dose steroids accelerate neurological recovery in inflammatory demyelination",
              "No focal signs suggesting active infection or alternative steroid contraindication on current data"
            ]
          },
          {
            "treatment": "Oral prednisolone taper following IV methylprednisolone",
            "timing": "Delay",
            "reasons": [
              "Only required after completion of IV course to reduce rebound symptoms",
              "Dose and duration should be tailored once response and side effects to IV therapy are seen"
            ]
          },
          {
            "treatment": "Proton pump inhibitor for gastroprotection",
            "timing": "Start Now",
            "reasons": [
              "High-dose corticosteroids increase risk of gastrointestinal irritation and ulceration",
              "Patient will likely receive several days of systemic steroids"
            ]
          },
          {
            "treatment": "Thromboprophylaxis with low-molecular-weight heparin and compression stockings while inpatient",
            "timing": "Start Now",
            "reasons": [
              "Reduced mobility from ataxia increases venous thromboembolism risk",
              "High-dose steroids further increase thrombotic risk"
            ]
          },
          {
            "treatment": "Physiotherapy and occupational therapy for gait and balance rehabilitation",
            "timing": "Start Now",
            "reasons": [
              "Cerebellar ataxia and unstable tandem gait predispose to falls",
              "Early rehabilitation improves functional outcomes and safety at home"
            ]
          },
          {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis (agent chosen per risk profile and guidelines)",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of MS diagnosis with MRI and CSF findings",
              "Baseline screening (blood tests, infection screen, pregnancy status where relevant) must precede therapy",
              "Choice of agent (e.g., ocrelizumab, natalizumab, fingolimod, interferon-beta) should follow multidisciplinary discussion and patient counselling"
            ]
          },
          {
            "treatment": "Vitamin D level assessment and supplementation if deficient",
            "timing": "Delay",
            "reasons": [
              "Low vitamin D is associated with increased MS disease activity",
              "Dose should be determined after laboratory confirmation to avoid hypervitaminosis D"
            ]
          },
          {
            "treatment": "Therapeutic plasma exchange",
            "timing": "Delay",
            "reasons": [
              "Reserved for steroid-refractory severe relapse or if NMOSD/MOG-associated disease is confirmed or strongly suspected",
              "Invasive therapy with significant risks; only indicated if inadequate improvement after steroid course"
            ]
          },
          {
            "treatment": "Patient education and counselling, including driving and employment advice",
            "timing": "Start Now",
            "reasons": [
              "Diagnosis or strong suspicion of demyelinating disease has major psychosocial impact",
              "Visual and gait impairment may affect driving safety and occupational activities, requiring early guidance"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Start Now",
            "reasons": [
              "Acute optic neuritis and cerebellar relapse causing functional impairment",
              "High-dose steroids accelerate neurological recovery in inflammatory demyelination",
              "No focal signs suggesting active infection or alternative steroid contraindication on current data"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint is not specified, so no indication whether this is related to MS.",
                "Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nCorrectly identified the following:\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not specified, so no indication what the current issue is and whether neurological signs are new or old.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Initiation of disease-modifying therapy for multiple sclerosis (agent chosen per risk profile and guidelines)",
            "timing": "Delay",
            "reasons": [
              "Requires confirmation of MS diagnosis with MRI and CSF findings",
              "Baseline screening (blood tests, infection screen, pregnancy status where relevant) must precede therapy",
              "Choice of agent (e.g., ocrelizumab, natalizumab, fingolimod, interferon-beta) should follow multidisciplinary discussion and patient counselling"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "Need a pregnancy test result.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 4,
          "reasons_acknowledged": 1,
          "reasons_missed": 3,
          "reasons_coverage_percentage": 0.25
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 4,
          "reasons_acknowledged": 3,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.75
        }
      }
    }
  }
}